BriaCell Therapeutics Corp. (OTCMKTS:BCTXF – Get Free Report)’s share price dropped 3.9% during trading on Wednesday . The stock traded as low as $0.56 and last traded at $0.57. Approximately 400,683 shares traded hands during mid-day trading, an increase of 21,454% from the average daily volume of 1,859 shares. The stock had previously closed at $0.60.
BriaCell Therapeutics Stock Performance
The company has a market capitalization of $609,108.00, a price-to-earnings ratio of -0.16 and a beta of 1.09. The business’s 50 day moving average is $0.78 and its 200 day moving average is $0.99.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.
Recommended Stories
- Five stocks we like better than BriaCell Therapeutics
- Industrial Products Stocks Investing
- Tesla Investors Continue to Profit From the Trump Trade
- What Does a Stock Split Mean?
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- Earnings Per Share Calculator: How to Calculate EPS
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
